The move follows mounting scrutiny over the significant difference in landing/base price and the MRP printed on medicines, medical devices and consumables. In several cases, patients are billed at or near MRP without any transparency about the actual acquisition cost, Karnataka FDA said in the circular dated October 1, 2026.